Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily

Asthma Drug Shows Promise Against Triple-Negative Breast Cancer and Resistant Tumors

Early Montelukast cancer research suggests a common asthma drug cancer treatment may help fight triple-negative breast cancer and other immunotherapy resistant cancers.

A common asthma medication used for decades is now drawing attention in cancer research after scientists found it may help the immune system fight some of the hardest cancers to treat. Researchers studying montelukast, a drug widely prescribed for asthma and allergies, say the medication showed encouraging results against aggressive tumors in early laboratory and animal studies.

Why Researchers Are Exploring Asthma Drug Cancer Treatment

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.